LENZ Therapeutics, Inc. Insider Transactions
LENZ Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Buy | 20 @ $22.71 | $454 | 3,208 | 11/07/2025 | 11/07/2025 | ||
| Buy | 2,178 @ $22.76 | $49.56 K | 5,386 | 11/07/2025 | 11/07/2025 | ||
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 123 @ $47.01 | $5.78 K | 764,127 | 09/30/2025 | 10/02/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 49,701 @ $45.35 | $2.25 M | 1,133,842 | 09/30/2025 | 10/02/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 57,502 @ $46.41 | $2.67 M | 764,250 | 09/30/2025 | 10/02/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 83,066 @ $46.41 | $3.85 M | 1,050,776 | 09/30/2025 | 10/02/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 34,405 @ $45.35 | $1.56 M | 821,752 | 09/30/2025 | 10/02/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 177 @ $47.01 | $8.32 K | 1,050,599 | 09/30/2025 | 10/02/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 40,907 @ $43.00 | $1.76 M | 1,183,811 | 09/18/2025 | 09/22/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 49,479 @ $41.59 | $2.06 M | 1,224,718 | 09/18/2025 | 09/22/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 24,370 @ $41.59 | $1.01 M | 876,437 | 09/18/2025 | 09/22/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 20,148 @ $43.00 | $866.44 K | 856,289 | 09/18/2025 | 09/22/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 268 @ $43.30 | $11.60 K | 1,183,543 | 09/18/2025 | 09/22/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 132 @ $43.30 | $5.72 K | 856,157 | 09/18/2025 | 09/22/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 21,661 @ $38.97 | $844.22 K | 902,514 | 08/26/2025 | 08/26/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 1,707 @ $39.50 | $67.43 K | 900,807 | 08/26/2025 | 08/26/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 3,465 @ $39.50 | $136.88 K | 1,274,197 | 08/26/2025 | 08/26/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 43,978 @ $38.97 | $1.71 M | 1,277,662 | 08/26/2025 | 08/26/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 50,270 @ $39.53 | $1.99 M | 1,323,789 | 08/25/2025 | 08/26/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 1,058 @ $39.92 | $42.24 K | 924,175 | 08/25/2025 | 08/26/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LENZ Therapeutics, Inc. FAQ's
The list of insiders at LENZ Therapeutics, Inc. includes Versant Venture Capital VI, L.P., Chevallard Daniel R..
Insiders have sold a total of 1.89 M LENZ Therapeutics, Inc. shares in the last 12 months for a total of 66.60 M sold.
The following insiders have sold LENZ Therapeutics, Inc. shares in the last 12 months: Versant Venture Capital VI, L.P. ($66.60 M),
Insiders have purchased a total of 2.20 K LENZ Therapeutics, Inc. shares in the last 12 months for a total of 50.02 K.
The following insiders have purchased LENZ Therapeutics, Inc. shares in the last 12 months: Chevallard Daniel R. ($50.02 K),